These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24223723)

  • 1. The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.
    Nicoli F; Finessi V; Sicurella M; Rizzotto L; Gallerani E; Destro F; Cafaro A; Marconi P; Caputo A; Ensoli B; Gavioli R
    PLoS One; 2013; 8(11):e77746. PubMed ID: 24223723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.
    Sicurella M; Nicoli F; Gallerani E; Volpi I; Berto E; Finessi V; Destro F; Manservigi R; Cafaro A; Ensoli B; Caputo A; Gavioli R; Marconi PC
    PLoS One; 2014; 9(7):e100844. PubMed ID: 25033084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Nicoli F; Gallerani E; Skarlis C; Sicurella M; Cafaro A; Ensoli B; Caputo A; Marconi PC; Gavioli R
    Vaccine; 2016 Apr; 34(19):2216-24. PubMed ID: 27002499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion.
    Ramachandran S; Davoli KA; Yee MB; Hendricks RL; Kinchington PR
    J Virol; 2010 Sep; 84(17):8811-20. PubMed ID: 20573821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.
    Ensoli B; Bellino S; Tripiciano A; Longo O; Francavilla V; Marcotullio S; Cafaro A; Picconi O; Paniccia G; Scoglio A; Arancio A; Ariola C; Ruiz Alvarez MJ; Campagna M; Scaramuzzi D; Iori C; Esposito R; Mussini C; Ghinelli F; Sighinolfi L; Palamara G; Latini A; Angarano G; Ladisa N; Soscia F; Mercurio VS; Lazzarin A; Tambussi G; Visintini R; Mazzotta F; Di Pietro M; Galli M; Rusconi S; Carosi G; Torti C; Di Perri G; Bonora S; Ensoli F; Garaci E
    PLoS One; 2010 Nov; 5(11):e13540. PubMed ID: 21085635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells.
    Treat BR; Bidula SM; Ramachandran S; St Leger AJ; Hendricks RL; Kinchington PR
    PLoS Pathog; 2017 Dec; 13(12):e1006732. PubMed ID: 29206240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Tat immunity defines CD4
    Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B
    EBioMedicine; 2021 Apr; 66():103306. PubMed ID: 33839064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors.
    Sforza F; Nicoli F; Gallerani E; Finessi V; Reali E; Cafaro A; Caputo A; Ensoli B; Gavioli R
    AIDS; 2014 Jul; 28(12):1729-38. PubMed ID: 24841128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1.
    Rajasagi NK; Kassim SH; Kollias CM; Zhao X; Chervenak R; Jennings SR
    J Virol; 2009 May; 83(10):5256-68. PubMed ID: 19279095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner.
    Chiozzini C; Collacchi B; Nappi F; Bauer T; Arenaccio C; Tripiciano A; Longo O; Ensoli F; Cafaro A; Ensoli B; Federico M
    AIDS; 2014 Sep; 28(15):2189-200. PubMed ID: 25313583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
    Nicoli F; Chachage M; Clowes P; Bauer A; Kowour D; Ensoli B; Cafaro A; Maboko L; Hoelscher M; Gavioli R; Saathoff E; Geldmacher C
    BMC Infect Dis; 2016 Jul; 16():344. PubMed ID: 27450538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
    J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    Gmyrek GB; Filiberti A; Montgomery M; Chitrakar A; Royer DJ; Carr DJJ
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
    Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.
    Klenner L; Hafezi W; Clausen BE; Lorentzen EU; Luger TA; Beissert S; Kühn JE; Loser K
    J Invest Dermatol; 2015 Nov; 135(11):2676-2687. PubMed ID: 26076314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection.
    Jones CM; Cose SC; Coles RM; Winterhalter AC; Brooks AG; Heath WR; Carbone FR
    J Virol; 2000 Mar; 74(5):2414-9. PubMed ID: 10666272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.